These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16227192)

  • 1. Improving clinical outcomes in coronary artery bypass graft surgery.
    Sedrakyan A
    Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S19-23. PubMed ID: 16227192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials.
    Sedrakyan A; Treasure T; Elefteriades JA
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):442-8. PubMed ID: 15354106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation.
    Levy JH
    Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S15-9. PubMed ID: 16227191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses.
    Møller CH; Penninga L; Wetterslev J; Steinbrüchel DA; Gluud C
    Eur Heart J; 2008 Nov; 29(21):2601-16. PubMed ID: 18628261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review and application of serine protease inhibition in coronary artery bypass graft surgery.
    Engles L
    Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S9-14. PubMed ID: 16227196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.
    Biancari F; Airaksinen KE; Lip GY
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):665-675.e4. PubMed ID: 21703636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of diabetic patients undergoing coronary artery bypass surgery compared with nondiabetics: a systematic review and meta-analysis.
    Zhang X; Wu Z; Peng X; Wu A; Yue Y; Martin J; Cheng D
    J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):288-98. PubMed ID: 21147538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
    Mangano DT; Miao Y; Vuylsteke A; Tudor IC; Juneja R; Filipescu D; Hoeft A; Fontes ML; Hillel Z; Ott E; Titov T; Dietzel C; Levin J; ;
    JAMA; 2007 Feb; 297(5):471-9. PubMed ID: 17284697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
    Al Ali J; Franck C; Filion KB; Eisenberg MJ
    JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease.
    Møller CH; Penninga L; Wetterslev J; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2012 Mar; (3):CD007224. PubMed ID: 22419321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.
    Peters DC; Noble S
    Drugs; 1999 Feb; 57(2):233-60. PubMed ID: 10188764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis.
    Naughton F; Wijeysundera D; Karkouti K; Tait G; Beattie WS
    Can J Anaesth; 2008 Dec; 55(12):827-35. PubMed ID: 19050086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation.
    Olivencia-Yurvati AH; Wallace WE; Wallace N; Dimitrijevich D; Knust JK; Haas L; Raven PB
    Perfusion; 2002 May; 17 Suppl():35-9. PubMed ID: 12009084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Mahmoud AN; Elgendy IY; Mentias A; Saad M; Ibrahim W; Mojadidi MK; Nairooz R; Eshtehardi P; David Anderson R; Samady H
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):541-552. PubMed ID: 28296170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-pump beating-heart technique is associated with lower morbidity and mortality following coronary artery bypass grafting: a meta-analysis.
    Ueki C; Sakaguchi G; Akimoto T; Ohashi Y; Sato H
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):813-821. PubMed ID: 27107048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study.
    Harmon DC; Ghori KG; Eustace NP; O'Callaghan SJ; O'Donnell AP; Shorten GD
    Can J Anaesth; 2004 Dec; 51(10):1002-9. PubMed ID: 15574551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.